Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior

NCT03149380 | Withdrawn

• 1 other identifier: 1311014539
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

To evaluate the effectiveness of an online educational course on Alzheimer's disease (AD) prevention, treatment and caregiving.

Conditions

Alzheimer Disease; Alzheimer Disease, Late Onset; Memory Loss; Patient Education as Topic

Outcome Measures

Primary Outcomes (2)

• Knowledge of AD Preventative behaviors

  Knowledge is calculated as a positive change on multiple-choice questions about AD between pre vs. post-completion of educational material

  12 months

• Willingness to Engage in AD Preventative behaviors

  Willingness is calculated as a positive change on questionnaires evaluating AD-preventative behaviors between pre vs. post-completion of educational material

  12 months

Secondary Outcomes (2)

• Participant Satisfaction

  12 months

• Behavioral Assessments

  12 months

Study Arms (2)

Intervention

EXPERIMENTAL

Subjects will be given access to educational content on AD using interactive learning strategies

Behavioral: Web-based education

Time-neutral control

SHAM COMPARATOR

Subjects will be given access to time-neutral general educational content on AD

Behavioral: Web-based education

Interventions

Web-based education BEHAVIORAL

The investigators will utilize interactive lessons and activities to educate about Alzheimer's disease prevention, treatment and caregiving, with focus on evidence-based lifestyle and nutritional recommendations that have been associated with delaying cognitive decline.

Intervention; Time-neutral control

Eligibility Criteria

• Age: 14 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• greater than or equal to 14 years old with a friend, family member or acquaintance with Alzheimer's disease or memory loss, OR a person diagnosed with mild memory loss (including mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease), OR an AD caregiver, OR healthcare providers, OR a medical student, college student or high school student.

You may not qualify if:

• \< 14 years old, OR diagnosis of moderate or severe Alzheimer's disease

Sponsors & Collaborators

• Weill Medical College of Cornell University: lead

Study Sites (1)

Weill Medical College of Cornell University

New York, New York, 10021, United States

Location

Related Links

• Direct hyperlink to Alzheimer's Universe website

MeSH Terms

Conditions

Alzheimer Disease; Memory Disorders

Condition Hierarchy (Ancestors)

Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Tauopathies; Neurodegenerative Diseases; Neurocognitive Disorders; Mental Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Richard Isaacson, MD

  Weill Medical College of Cornell University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 13, 2017
• First Posted: May 11, 2017
• Study Start: January 1, 2017
• Primary Completion: December 1, 2023
• Study Completion: October 1, 2024
• Last Updated: March 22, 2023

Record last verified: 2023-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)